Maverix Medical Expands the Narwhal™ Cryo Portfolio with FDA Clearance of the Narwhal Pro

RegulatoryapprovedNarwhal ProPositive

AI Analysis

Summary

Maverix Medical received FDA clearance for the Narwhal Pro, a console-free cryoprobe designed for bronchoscope compatibility and improved probe positioning control in lung cancer diagnosis and treatment.

Outcome Details

FDA clearance of Narwhal Pro cryoprobe, second console-free cryoprobe in Narwhal portfolio

Importance:6/10

Sentiment:

0.70

FDA clearancemedical devicelung cancercryoprobeproduct expansion

Related Companies

$MDCE

Read the original article

Published by PR Newswire Biotech on October 14, 2026 11:50 AM

Read Original